Analysis of the Asia-Pacific Molecular Diagnostics Market

INDUSTRY
Healthcare
SECTOR
Life Sciences

RELEASE DATE
16-Apr-2013
REGION
Asia Pacific
DELIVERABLE TYPE
Market Research

RESEARCH CODE
P6F6-01-00-00-00
SKU
LS00138-AP-MR_16979
Yes
SHARE

Analysis of the Asia-Pacific Molecular Diagnostics Market
Published on: 16-Apr-2013 | SKU: LS00138-AP-MR_16979

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

This Market Engineering research services is to analyze and evaluate the molecular diagnostics market in the Asia-Pacific region. This research covers four segments, namely infectious diseases, genetic diseases, oncology, and pharmacogenomics. It provides insights and analysis on current and future trends, market drivers, market restraints, revenue forecast, competitive analysis, and the market share of key participants in this market. This research service also presents the country analysis of selected emerging markets in Asia-Pacific to explore the challenges and opportunities in this market.

Executive Summary

Executive Summary (continued)

Executive Summary—Market Engineering Measurements

Executive Summary—CEO’s Perspective

Market Overview—Definitions

Market Overview—Definitions (continued)

Market Overview—Definitions (continued)

Market Overview—Key Questions

Market Overview—Research Scope and Objectives

Market Overview—Molecular Diagnostics Market Segmentation

Market Overview— Geographic Segmentation

Market Overview—Segmentation

Market Overview—Life Cycle Analysis

Drivers and Restraints

Market Drivers Explained

Market Drivers Explained (continued)

Market Drivers Explained (continued)

Market Drivers Explained (continued)

Market Restraints Explained

Market Restraints Explained (continued)

Market Restraints Explained (continued)

Market Engineering Measurements

Forecast Methodology

Forecast Assumptions

Total Molecular Diagnostics Market—Revenue Forecast

Revenue Forecast Discussion

Total Molecular Diagnostics Market—Revenue Forecast by Country

Total Molecular Diagnostics Market—Percent Revenue Forecast by Segments

Total Molecular Diagnostics Market—Segment Growth Analysis

Competitive Analysis—Market Share

Market Share Analysis

Competitive Environment

Top Competitors Analysis

Top Competitors Analysis (continued)

Competitive Landscape Analysis

Infectious Diseases Segment Overview

Infectious Diseases Segment—Market Engineering Measurements

Infectious Diseases Segment—Revenue Forecast

Infectious Diseases Segment—Revenue Forecast Discussion

Oncology Segment Overview

Oncology Segment—Market Engineering Measurements

Oncology Segment Revenue Forecast

Oncology Segment—Revenue Forecast Discussion

Genetic Diseases Segment Overview

Genetic Diseases Segment—Market Engineering Measurements

Genetic Diseases Segment—Revenue Forecast

Genetic Diseases Segment—Revenue Forecast Discussion

Pharmacogenomics Segment Overview

Pharmacogenomics Segment—Market Engineering Measurements

Pharmacogenomics Segment—Revenue Forecast

Pharmacogenomics Segment—Revenue Forecast Discussion

Australia—Country Overview

Australia—Healthcare System and Reimbursement Structure

Australia Market—Revenue Forecast

Australia Market—Revenue Forecast Discussion

South Korea—Country Overview

South Korea—Healthcare System and Reimbursement Structure

South Korea—Healthcare System and Reimbursement Structure (continued)

South Korea Market—Revenue Forecast

South Korea Market—Revenue Forecast Discussion

Malaysia—Country Overview

Malaysia—Healthcare System and Reimbursement Structure

Malaysia Market—Revenue Forecast

Malaysia Market—Revenue Forecast Discussion

Thailand—Country Overview

Thailand—Healthcare System and Reimbursement Structure

Thailand Market—Revenue Forecast

Thailand Market—Revenue Forecast Discussion

Indonesia—Country Overview

Indonesia—Healthcare System and Reimbursement Structure

Indonesia Market—Revenue Forecast

Indonesia Market—Revenue Forecast Discussion

Vietnam—Country Overview

Vietnam—Healthcare System and Reimbursement Structure

Vietnam Market—Revenue Forecast

Vietnam Market—Revenue Forecast Discussion

The Last Word—5 Key Trends to Watch

The Last Word—Three Big Predictions

Legal Disclaimer

Market Engineering Methodology

List of Asia-Pacific IVD Reports @ Frost.com

Decision Support Database—Total Healthcare Expenditure

Decision Support Database—Public Healthcare Expenditure

Decision Support Database—Private Healthcare Expenditure

Decision Support Database—Total Population


Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Life Sciences research

13 Jan 2025   |   Global   |   Market Outlook

Top 6 Growth Opportunities for the Digital Health Industry, 2025

Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...

17 Dec 2024   |   Global   |   Market Research

Cybersecurity in Healthcare, United States, 2024

Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...

12 Dec 2024   |   Global   |   Market Outlook

Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025

Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...

05 Dec 2024   |   Global   |   Frost Radar

Frost Radar™: Enterprise Conversational AI in Healthcare, 2024

This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...

27 Nov 2024   |   Global   |   Market Research

Generative AI in Payer and Provider IT Transformation, Global, 2024-2029

The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

This Market Engineering research services is to analyze and evaluate the molecular diagnostics market in the Asia-Pacific region. This research covers four segments, namely infectious diseases, genetic diseases, oncology, and pharmacogenomics. It provides insights and analysis on current and future trends, market drivers, market restraints, revenue forecast, competitive analysis, and the market share of key participants in this market. This research service also presents the country analysis of selected emerging markets in Asia-Pacific to explore the challenges and opportunities in this market.
More Information
Deliverable Type Market Research
No Index No
Podcast No
WIP Number P6F6-01-00-00-00
Is Prebook No

Analysis of the Asia-Pacific Molecular Diagnostics Market

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
LS00138-AP-MR_16979